During the 5th Digital Rheumatology Day three companies will present their digital solutions that aim to improve quality of care in rheumatology for patients and their doctors. Are you convinced of their solutions? Could this improve rheumatology care? Join us in...
Apps & DTx
RheumaBuddy
RheumaBuddy is one of the frontrunners in digital therapeutics in rheumatology. It was launched in its first version in 2014 and is currently available in most European countries. It is used by more than 20.000 patients, with the aim of improving Quality of Life of...
Webinar Pain DTx
WATCH THE WHOLE RECORDED WEBINAR! The health care system is undergoing fundamental changes due to digitalization. There is growing evidence that digital therapeutics can effectively improve the course of diseases. Digital therapeutics (DTx) can be prescribed by...
Interview with Matthias Diener from the Health Start-up Digital Rheuma Lab
Nice to have you, could you tell a bit, who you are? Hey Sina, sure thing! I am Matthias Diener, one of the Co-Founders of the Berlin based Health Startup Digital Rheuma Lab, thanks for having me! As your company´s name may suggest, you are involved in Digital...
Winner of the Pitching Event during the 4th Digital Rheumatology Day
The last session of the 4th Digital Rheumatology Day focused on a pitch competition for innovative digital solutions. Three companies were invited to present their 3-minute pitch videos and to convince the audience on how their solution can improve quality of care in...
Current Status of the DIGA Registry in Germany Regarding Musculoskeletal Disorders
There is growing evidence that digital therapeutics can effectively improve the course of diseases. Mostly chronic disorders are addressed by behaviour change or exercise programs. In Germany, so-called DIGAs (Digitale Gesundheits Anwendung = Digital Health...
Health-Related Quality of Life Improvements in Systemic Lupus Erythematosus Derived from a Digital Therapeutic Plus Tele-Health Coaching Intervention: Randomized Controlled Pilot Trial
Background:Â Systemic lupus erythematosus (SLE), a systemic autoimmune disease with no known cure, remains poorly understood and patients suffer from many gaps in care. Recent work has suggested that dietary and other lifestyle factors play an important role in...
Digital rheumatology in the era of COVID-19: results of a national patient and physician survey
Objective To analyse the impact of the COVID-19 pandemic on rheumatic patients’ and rheumatologists’ usage, preferences and perception of digital health applications (DHAs). Methods A web-based national survey was developed by the Working Group Young...
Mobile Health in Rheumatology: A Patient Survey Study exploring Usage, Preferences, Barriers and eHealth Literacy
Background: Mobile Health (mHealth) defines the support and practice of health care using mobile devices and promises to improve the current treatment situation of patients with chronic diseases. Little is known about mHealth usage and digital preferences of patients...
Cloudy With A Chance of Pain
The talk will describe our national smartphone study Cloudy with a Chance of Pain, exploring aspects of its set-up, recruitment and retention, analysis and public engagement. For thousands of years, there has been a belief by people living with long-term...
Apps und ihre Anwendungsgebiete in der Rheumatologie
The increasing use of smartphones is accompanied by a significant increase in the use of mobile applications (apps). Chronically ill patients could permanently profit from this development.This development is fuelled by the Digital Healthcare Act (DVG), whereby...